11-66756337-CT-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The ENST00000525449.6(C11orf80):c.-149-6del variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0152 in 1,081,708 control chromosomes in the GnomAD database, including 84 homozygotes. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.011 ( 12 hom., cov: 31)
Exomes 𝑓: 0.016 ( 72 hom. )
Consequence
C11orf80
ENST00000525449.6 splice_polypyrimidine_tract, intron
ENST00000525449.6 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.538
Genes affected
C11orf80 (HGNC:26197): (TOP6B like initiator of meiotic double strand breaks) Predicted to be involved in meiotic DNA double-strand break formation and reciprocal meiotic recombination. Predicted to be located in chromosome. Implicated in gestational trophoblastic neoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 11-66756337-CT-C is Benign according to our data. Variant chr11-66756337-CT-C is described in ClinVar as [Likely_benign]. Clinvar id is 3055765.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0111 (1659/149214) while in subpopulation NFE AF= 0.0159 (1066/67076). AF 95% confidence interval is 0.0151. There are 12 homozygotes in gnomad4. There are 760 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 12 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C11orf80 | NM_001302084.2 | c.-29-2696del | intron_variant | ENST00000540737.7 | NP_001289013.1 | |||
C11orf80 | NM_024650.3 | c.317-6del | splice_polypyrimidine_tract_variant, intron_variant | NP_078926.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C11orf80 | ENST00000540737.7 | c.-29-2696del | intron_variant | 2 | NM_001302084.2 | ENSP00000444319 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0111 AC: 1659AN: 149118Hom.: 12 Cov.: 31
GnomAD3 genomes
AF:
AC:
1659
AN:
149118
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0411 AC: 1044AN: 25382Hom.: 6 AF XY: 0.0407 AC XY: 566AN XY: 13902
GnomAD3 exomes
AF:
AC:
1044
AN:
25382
Hom.:
AF XY:
AC XY:
566
AN XY:
13902
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0158 AC: 14737AN: 932494Hom.: 72 Cov.: 24 AF XY: 0.0158 AC XY: 7123AN XY: 450934
GnomAD4 exome
AF:
AC:
14737
AN:
932494
Hom.:
Cov.:
24
AF XY:
AC XY:
7123
AN XY:
450934
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0111 AC: 1659AN: 149214Hom.: 12 Cov.: 31 AF XY: 0.0104 AC XY: 760AN XY: 72734
GnomAD4 genome
AF:
AC:
1659
AN:
149214
Hom.:
Cov.:
31
AF XY:
AC XY:
760
AN XY:
72734
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
TOP6BL-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 22, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at